-
Start Preamble
Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 31, 2005, Clariant LSM (Missouri), Inc., 2460 W. Bennett Street (or P.O. Box 1246, Zip: 65801), Springfield, Missouri 65807-1229, made application by letter to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of Phenylacetone (8501), and Methadone Intermediate (9254), a basic class of controlled substances listed in Schedule II.
The company plans to manufacture in bulk, for sale to its customers.
Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than March 24, 2006.
Start SignatureDated: January 11, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E6-719 Filed 1-20-06; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 01/23/2006
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Document Number:
- E6-719
- Pages:
- 3545-3545 (1 pages)
- PDF File:
- e6-719.pdf